Literature DB >> 10544008

VAMP-1 has a highly variable C-terminus generated by alternative splicing.

L Berglund1, H J Hoffmann, R Dahl, T E Petersen.   

Abstract

VAMP-1 (synaptobrevin1) is one of the key proteins in the SNARE complex which is involved in regulated exocytosis. Recently, Isenmann et al. (1998, Mol. Biol. Cell 9, 1649-1660) showed the extreme C-terminal region of VAMP-1A and 1B to be involved in subcellular targeting of the isoforms. Four new splice variants (VAMP-1C to F) were identified in addition to the previously published variants VAMP-1A and VAMP-1B. Interestingly, the four new isoforms also have variable sequences only at the extreme C-terminus. This suggests that the C-terminal region has an important function for VAMP-1 and vesicle targeting. All six variants were a result of alternative splicing that linked exons 1-4 which encode the conserved region of VAMP-1 with one of the exons 5A to 5F that encodes the highly variable extreme C-terminus. Exon (5A-E) encode C-termini of two to five amino acid residues, whereas exon 5F encoded a long C-terminal amino acid extension. The splice variants were differentially expressed in human brain, kidney, and inflammatory cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544008     DOI: 10.1006/bbrc.1999.1588

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Endothelial transcytotic machinery involves supramolecular protein-lipid complexes.

Authors:  S A Predescu; D N Predescu; G E Palade
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

2.  Effect of rabies virus infection on gene expression in mouse brain.

Authors:  M Prosniak; D C Hooper; B Dietzschold; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  A null mutation in VAMP1/synaptobrevin is associated with neurological defects and prewean mortality in the lethal-wasting mouse mutant.

Authors:  Arne M Nystuen; Jamie K Schwendinger; Andrew J Sachs; Andy W Yang; Neena B Haider
Journal:  Neurogenetics       Date:  2006-11-11       Impact factor: 2.660

4.  Identification of a novel Vamp1 splice variant in the cochlear nucleus.

Authors:  David R Friedland; Rebecca Eernisse; Paul Popper
Journal:  Hear Res       Date:  2008-07-09       Impact factor: 3.208

5.  VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families.

Authors:  Cynthia V Bourassa; Inge A Meijer; Nancy D Merner; Kanwal K Grewal; Mark G Stefanelli; Kathleen Hodgkinson; Elizabeth J Ives; William Pryse-Phillips; Mandar Jog; Kym Boycott; David A Grimes; Sharan Goobie; Richard Leckey; Patrick A Dion; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2012-09-07       Impact factor: 11.025

6.  Alternative splicing of the human gene SYBL1 modulates protein domain architecture of Longin VAMP7/TI-VAMP, showing both non-SNARE and synaptobrevin-like isoforms.

Authors:  Marcella Vacca; Lara Albania; Floriana Della Ragione; Andrea Carpi; Valeria Rossi; Maria Strazzullo; Nicola De Franceschi; Ornella Rossetto; Francesco Filippini; Maurizio D'Esposito
Journal:  BMC Mol Biol       Date:  2011-05-24       Impact factor: 2.946

7.  NFAT1 and NFAT3 cooperate with HDAC4 during regulation of alternative splicing of PMCA isoforms in PC12 cells.

Authors:  Michalina Kosiorek; Paulina Podszywalow-Bartnicka; Ludmila Zylinska; Slawomir Pikula
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

8.  Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndrome.

Authors:  Xin-Ming Shen; Rosana H Scola; Paulo J Lorenzoni; Cláudia S K Kay; Lineu C Werneck; Joan Brengman; Duygu Selcen; Andrew G Engel
Journal:  Ann Clin Transl Neurol       Date:  2017-01-16       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.